Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-daily versus standard twice-daily raltegravir and etravirine pharmacokinetics in adults with HIV-1 infection
2009-014480-39Phase 4Active
- Sponsor
- Luis Fernando López Cortés
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of raltegravir and etravirine in Human immunodeficiency virus infection type 1 (2 cohorts), sponsored by Luis Fernando López Cortés. Primary endpoint: Plasma and intracellular concentrations of raltegravir and etravirine. Started Apr 2010; status: active.
02
Drugs
raltegraviretravirine
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2009-014480-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014480-39.